ECM
MR

ETrade Capital Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

ETrade Capital Management’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-28,951
Closed -$937K – 794
2014
Q1 		$937K Buy
28,951
+6,111
+27% +$214K 0.07% 215
2013
Q4 		$831K Buy
22,840
+22
+0.1% +$855 0.07% 215
2013
Q3 		$887K Buy
22,818
+5,526
+32% +$223K 0.08% 164
2013
Q2 		$648K Buy
+17,292
New +$683K 0.07% 175

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

ETrade Capital Management's MR Position: Q2 2014 in Review

ETrade Capital Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2014, closing a stake of 28,951 shares — an estimated $937K sold.

ETrade Capital Management first reported a position in MR in Q2 2013 and held it in 4 quarters. The position peaked at $937K in Q1 2014. 131 funds tracked by Wall St. Rank hold MR as of Q2 2014.

  • ETrade Capital Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2014 after selling out during the quarter.
  • ETrade Capital Management sold 28,951 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2014, an estimated $937K.
  • ETrade Capital Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 4 quarters.
  • ETrade Capital Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $937K in Q1 2014.
  • 131 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2014.

Based on ETrade Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.